Dompe U.S. Inc.
UnclaimedPharmaceutical Preparation ManufacturingSan Mateo, CA
Founded
2013
Primary NAICS
325412
CAGE code
89P46
Federal awards
$1.1M
Overview
Dompé advances research on rhNGF, its biotech pipeline and Exscalate to develop ophthalmic therapies and innovative technologies for clinicians.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $241,160 | 10 |
| 2025 | Department of Veterans Affairs | $475,550 | 21 |
| 2024 | Department of Veterans Affairs | $115,843 | 11 |
| 2023 | Department of Veterans Affairs | $280,103 | 11 |
| 2022 | Department of Veterans Affairs | $8,025 | 15 |